# Atrial Fibrillation and By-pass Surgery

> **NCT01955759** · EARLY_PHASE1 · UNKNOWN · sponsor: **Heart Center BH Tuzla** · enrollment: 260 (estimated)

## Conditions studied

- Patients With Coronary Artery Disease Scheduled for by Pass Surgery

## Interventions

- **DRUG:** Amiodarone tab 200 mg x 3
- **DRUG:** rosuvastatin 20 mg tab x1
- **DRUG:** beta blockers Bisoprolol in adjusted dose

## Key facts

- **NCT ID:** NCT01955759
- **Lead sponsor:** Heart Center BH Tuzla
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2014-12
- **Final completion:** 2015-02
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2013-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01955759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01955759, "Atrial Fibrillation and By-pass Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01955759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*